{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "HELE",
  "name": "Helen of Troy Limited",
  "url": "https://orbyd.app/dossiers/HELE/",
  "json_url": "https://orbyd.app/dossiers/HELE.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "The 2026-07-08 double beat was sold — closed $25.18, -10.2% — because margins compressed (GM 46.0%, -110bp; adj EPS $0.17 vs $0.41). The live leg is now deleveraging: net leverage 3.48x from 3.87x, debt $716.1M from $871.0M, FY27 FCF guided $85–100M, at 7.55x forward on a $644M equity stub inside a $1.39B EV. Chopping $25.13–$29.65 since; no print until ~October.",
  "invalidation_trigger": "A daily close below $25 forfeits the post-print floor set by the 2026-07-08 low of $25.13 and the 50-DMA near $27.30, reopening the $21 area; secondarily, net leverage flat or above 3.48x at the ~2026-10-08 Q2 print, or the FY2027 free-cash-flow guide cut below $85M.",
  "catalyst_date": "2026-08-25",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation",
    "m-and-a-special-situations",
    "freight-logistics"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Bermuda-domiciled with a fiscal year ending late February: FY2027 runs Mar 2026-Feb 2027, so quarter labels lead the calendar year by roughly ten months.",
    "GAAP EPS is not a run-rate here — FY2026 showed a $39.08 diluted loss per share on impairments and Q1 FY2027's $1.51 includes a ~$55M pre-tax facility-sale gain. The adjusted line is the comparable one.",
    "A securities class action is pending covering purchases from 2024-04-24 to 2025-10-08 over Project Pegasus restructuring disclosures; CFO Brian Grass is a named individual defendant.",
    "Small float: 23.29M shares outstanding and a $643.56M market cap at 2026-07-31, with short interest at 11.71% of float — moves run large on modest volume.",
    "The equity is a thin slice of enterprise value: $1.39B EV against $716.1M total debt and $21.7M cash at the 2026-05-31 quarter end."
  ],
  "body_markdown": "## Current Thesis\n\nThe binary that framed the last note resolved on 2026-07-08, and the tape voted against the result. Q1 FY2027 beat on both lines — net sales **$402.1M, +8.2% YoY** against a consensus near $374.6M, adjusted diluted EPS **$0.17** against a consensus of roughly breakeven — What got priced was the margin structure beneath the beat: gross margin **46.0% (-110bp YoY)**, adjusted operating margin **4.0% (-30bp)**, adjusted EBITDA margin **6.3% from 6.9%**, and adjusted EPS of $0.17 against **$0.41** in the year-ago quarter. Revenue recovered; the earnings power behind it did not.\n\nThe leg still standing is the balance sheet, and it is now the whole argument. Net leverage came in at **3.48x from 3.87x** at the February year-end, total debt fell to **$716.1M from $871.0M** a year earlier, and management guided FY2027 free cash flow of **$85–$100M** with a year-end net-leverage target of **3.2x or lower**. A $643.56M equity market cap sits beneath $716.1M of debt inside a **$1.39B enterprise value** — every turn of leverage retired lands disproportionately on the share line. At **7.55x forward earnings**, that is what an investor is buying: a deleveraging stub priced as though the deleveraging is optional.\n\nSince the print the stock has settled nothing. Seventeen sessions between the 2026-07-08 low of **$25.13** and the 2026-07-28 high of **$29.65**, closing 2026-07-31 at **$27.63** — above a 200-DMA of $21.15, marginally above a 50-DMA of $27.30, and above the Street's $26.50 average target. No scheduled print until roughly October.\n\n## Bull Case\n\n- **Deleveraging is measured, not just promised (2026-07-08):** net leverage **3.48x** versus 3.87x at the FY2026 close; total debt **$716.1M** versus $871.0M a year earlier. Management attached a number to the next step — 3.2x or lower at fiscal year-end.\n- **Both segments grew (2026-07-08):** Home & Outdoor **$194.9M (+9.5%)**, Beauty & Wellness **$207.2M (+7.0%)**. The FY2027 segment guide is $859–884M and $900–947M respectively.\n- **The guide was raised into a cautious consumer (2026-07-08):** FY2027 net sales lifted to **$1.759B–$1.831B** (midpoint ~$1.795B) with adjusted EPS held at **$3.25–$3.75**.\n- **Cash conversion is guided to return (2026-07-08):** FY2027 free cash flow of **$85–$100M** after Q1 printed **-$6.4M**, helped by ~$9.2M of phase-one tariff refunds expected for the year, of which the bulk of the remaining ~$7M was guided as collectible in Q2.\n- **Valuation carries the case:** **7.55x forward**, $643.56M market cap on **23.29M shares** (2026-07-31), against FY2026 adjusted EBITDA of **$185.8M** and a brand set including OXO, Hydro Flask, Osprey, Braun, Vicks and Drybar.\n- **No insider selling into the recovery:** the 2026 Form 4 record is restricted stock and tax withholding — CEO G. Scott Uzzell awarded **109,289** restricted shares on 2026-03-06 (direct holdings to 240,761); CFO Brian Grass had **1,288** shares withheld at $17.64 on 2026-03-01. No open-market insider sale appears on the record while the stock roughly doubled off its $13.85 52-week low.\n\n## Bear Case\n\n- **The beat was sold (2026-07-08):** -10.2% to $25.18. A double beat that closes down double digits shifts the question from the quarter to the durability of the guide.\n- **Margins still moving the wrong way (2026-07-08):** gross margin 46.0% (-110bp), adjusted operating margin 4.0% (-30bp), adjusted EPS $0.17 versus $0.41. The topline is being bought with margin.\n- **Cash flow inverted (2026-07-08):** operations *used* $0.6M in Q1 FY2027 versus generating **$58.3M** in Q1 FY2026; free cash flow -$6.4M versus +$45.0M. The $85–$100M full-year guide now rests entirely on the remaining three quarters.\n- **Price sits through the Street (2026-07-29 to 07-31):** consensus Hold, average one-year target **$26.50**, against a $27.63 close. Upside from here requires estimate revisions rather than multiple catch-up.\n- **Litigation names the sitting CFO (deadline 2026-08-03):** a securities class action covering purchasers from 2024-04-24 through 2025-10-08 alleges Project Pegasus restructuring targets were publicly affirmed without the resources budgeted to hit them. CFO Brian Grass is a named individual defendant.\n- **GAAP and adjusted tell different stories:** FY2026 (ended 2026-02-28) net sales $1,786.3M with an **operating loss of $782.1M**, net loss **$899.0M**, diluted loss per share **$39.08**; Q1 FY2027 GAAP EPS of $1.51 includes a ~$55M pre-tax gain on a Mississippi facility sale. The adjusted series is the only comparable one — which is precisely what the litigation contests.\n- **Supply-chain warning still live (2026-07-08):** management flagged Middle East conflict as a potential disruption to supply and revenue, on top of tariff exposure.\n\n## Setup & Price Structure\n\n**Life-cycle: MATURING.** What dates it: print-day and next-day volumes of **1,246,871 (2026-07-08)** and **1,282,353 (2026-07-09)** decayed to **287,532–390,333** across the final five sessions of July — participation contracting, not expanding. The structure is intact: a rising 200-DMA at **$21.15** sits well beneath a $27.63 close, and the 2026-07-08 session low of $25.13 held the $25 line that has framed this name since June. But the fresh-attention phase is behind it — July's incremental research flow was four ratings touches (UBS and Canaccord 2026-07-09, Wall Street Zen 2026-07-12, Weiss 2026-07-21) resolving to a Hold consensus, which is coverage without a new bid.\n\nLevels:\n\n- **$25.13** — 2026-07-08 intraday low, the post-print floor.\n- **$27.30** — 50-DMA at 2026-07-31; the close sat $0.33 above it.\n- **$29.65 / $30.34** — 2026-07-28 intraday high and 2026-07-01 high, the month's ceiling. 52-week range $13.85–$30.68.\n- **$21.15** — 200-DMA, the structural line beneath the recovery off $13.85.\n\nCrowding and positioning, as observed rather than judged:\n\n- Borrow of that size on a float this small cuts in both directions on any surprise.\n- The 2026-07-31 close ($27.63) is **above** the consensus one-year target ($26.50).\n- No earnings inside 30 days; the next print is roughly ten weeks out.\n- An **equity-issuance proposal is on the 2026-08-25 ballot** — an amendment increasing shares available under the 2025 Stock Incentive Plan — after the stock roughly doubled off its 52-week low.\n- The retail-facing headline clustering is plaintiff solicitation: SueWallSt (2026-06-11), The Gross Law Firm (2026-07-14, 2026-07-31), Levi & Korsinsky (2026-07-15, 2026-07-20, 2026-07-22) and Bragar Eagel (2026-07-27).\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-25, 10:00 a.m. EDT — Annual general meeting (virtual-only).** Four items per the DEF 14A filed 2026-06-24: election of nine directors, advisory say-on-pay, an amendment increasing shares available under the 2025 Stock Incentive Plan, and appointment of Grant Thornton LLP as FY2027 auditor. The share-increase vote puts a number on planned issuance against 23.29M shares outstanding; say-on-pay reads shareholder tolerance for the reset after an $899.0M FY2026 net loss.\n- **~2026-10-08 (est.) — Q2 FY2027 results** for the quarter ending 2026-08-31 (prior-year Q2 was reported 2025-10-09). Outside the 30-day window. It is the first check on net leverage against the ≤3.2x year-end target, on whether gross margin stops eroding below 46.0%, and on collection of the ~$7M of phase-one tariff refunds guided into Q2.\n\n## Elapsed catalysts\n\n- **2026-08-03 — Lead-plaintiff deadline, HELE securities class action.** Court-set date for class-representative applications; class period 2024-04-24 to 2025-10-08. Nothing about the merits resolves here — the case consolidates, which starts the clock on legal expense and discovery-driven disclosure with the sitting CFO named individually. *(passed 6d ago)*\n\n## What Would Change Our Mind\n\nThe structure that has to hold is the post-print floor. The 2026-07-08 low of $25.13 and close of $25.18 sat five cents above the $25 line, and that line was approached again on 2026-07-23. **A daily close below $25** forfeits that floor along with the 50-DMA near $27.30 and reopens the $21 area where the 200-DMA sits.\n\nThree fundamental breaks, each observable on a date:\n\n- **Deleveraging stalls.** Net leverage flat or above 3.48x at the Q2 print (~2026-10-08, est.), or the FY2027 free-cash-flow guide cut below $85M. The equity case here is arithmetic on debt reduction; at a 4.0% adjusted operating margin there is little else holding it up.\n- **Margin keeps compressing while the guide is held.** Q2 gross margin printing below 46.0% with the $3.25–$3.75 adjusted EPS range unchanged would mean the guide depends on volume the consumer has not committed to.\n- **The theme flips to SATURATED.** Mainstream deep-value coverage arriving while volume keeps contracting from the 1.25M print-day level, with price still above the $26.50 consensus target, would mark late-cycle flow into a thin bid.\n\nThe observable that would strengthen the case instead: a Q2 net-leverage print at or below 3.2x — ahead of the year-end target — with gross margin flat or better. That converts the balance-sheet argument from guidance into a trend and would force sell-side targets above the current $26.50 average.\n\n## Correlation Notes\n\n**Measured:** beta 1.31 on a five-year basis (2026-07-31). Enterprise value $1.39B against $643.56M of equity value, so the shares behave as a levered claim — enterprise-level moves arrive amplified at the share line.\n\n**Inferred, and labelled as such.** Three correlations run here. First, the small-cap levered-value cohort: with $716.1M of debt against $21.7M of cash at 2026-05-31, credit conditions and the front end of the rate curve matter more to this equity than to an unlevered peer. Second, the discretionary-durables complex — Newell Brands, YETI, Solo Brands, Spectrum Brands — on consumer-spending prints and retailer restocking commentary; Q1's +9.5% and +7.0% segment growth came off the same shelf space those names compete for. Third, the China-sourced import basket: phase-one refund timing is a shared line item across importers, and the ~$7M expected in Q2 is a policy-driven cash flow, not an operating one.\n\nThe 11.71% short-of-float reading (2026-07-31) adds an episodic fourth: on sessions when high-short-interest small caps move together, a 23.29M-share count means the move lands larger than the fundamentals warrant in either direction. That relationship is mechanical and carries no directional information.",
  "first_seen": "2026-04-24",
  "last_analyzed": "2026-08-01T09:46:59+00:00",
  "last_synthesized": "2026-08-01",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}